Caenorhabditis elegans pharyngeal muscle development involves ceh-22, an NK-2 family homeobox gene related to genes controlling heart development in other species. ceh-22 is the earliest known gene expressed in the pharyngeal muscles and is likely regulated directly by factors specifying pharyngeal muscle fate. We have previously implicated the ceh-22 distal enhancer in initiating ceh-22 expression. Here we analyze the distal enhancer using functional and comparative assays. The distal enhancer contains three subelements contributing additively to its activity, and functionally important regulatory sequences are highly conserved in Caenorhabditis briggsae. One subelement, termed DE3, is strongly active in the pharyngeal muscles, and we identified two short oligonucleotides (de199 and de209) contributing to DE3 activity. Multimerized de209 enhances transcription similarly to DE3 specifically in the pharyngeal muscles, suggesting it may be an essential site regulating ceh-22. de209 binds the pan-pharyngeal Forkhead factor PHA-4 in vitro and responds to ectopic pha-4 expression in vivo, suggesting that PHA-4 directly initiates ceh-22 expression through de209. Because de209 enhancer activity is primarily limited to the pharyngeal muscles, we hypothesize that de209 also binds factors functioning with PHA-4 to specifically activate ceh-22 expression in pharyngeal muscle. D
Introduction
The mechanisms controlling heart specification and differentiation are conserved in species as diverged as Drosophila and humans. At the center of this mechanism are NK-2 homeobox genes related to Drosophila tinman and the vertebrate nkx2.5 genes (for review, see Cripps and Olson, 2002; Srivastava, 2001) . These genes are expressed early in a program of heart differentiation and play crucial roles in specifying cardiac fate and in regulating cardiac gene expression.
Nematodes do not have hearts. However, development of the Caenorhabditis elegans pharynx involves the NK-2 family homeobox gene ceh-22. ceh-22 is one of the four NK-2 homeobox genes in C. elegans, and it is exclusively expressed in the pharyngeal muscles (Consortium, 1998; Harfe and Fire, 1998; Okkema and Fire, 1994) . ceh-22 is necessary for normal pharyngeal muscle function and gene expression (Okkema et al., 1997) , and it can be functionally replaced by the zebrafish nkx2.5 (Haun et al., 1998) . Together these results suggest that the mechanisms regulating nematode pharyngeal development share common features with those regulating heart development in other species.
The C. elegans pharynx is a rhythmically contracting tube that functions in the digestive system to pump a suspension of bacteria through a central lumen into the gut. It consists of five very different cell types (muscles, neurons, epithelial cells, secretory gland cells, and structural epithelial cells called marginal cells) (Albertson and Thomson, 1976) . The pharynx is produced from two blastomeres called ABa and MS (Sulston et al., 1983) , which are specified by distinct genetic mechanisms (for review, see Bowerman, 1998) , and the pharyngeal primordium forms about half-way through embryogenesis as a compact group of undifferentiated cells surrounded by a distinct basement membrane (Sulston et al., 1983) . These cells subsequently differentiate, and the pharynx undergoes morphogenesis to form the characteristic bilobed organ before hatching. The pharynx increases in size during postembryonic development, but there are no cell divisions after formation of the pharyngeal primordium (Sulston et al., 1983) .
Formation of the pharyngeal primordium and differentiation of all pharyngeal cell types require PHA-4, a FOXA family Forkhead domain transcription factor (Horner et al., 1998; Kalb et al., 1998; Mango et al., 1994) . PHA-4 is expressed in all pharyngeal cells (Horner et al., 1998; Kalb et al., 1998) , and it may directly regulate all genes expressed in the pharynx (Gaudet and Mango, 2002) . In the pharyngeal muscles, PHA-4 functions with CEH-22 to activate expression of the pharyngeal muscle-specific myosin gene myo-2 (Kalb et al., 1998; Okkema and Fire, 1994) . Likewise, PHA-4 and CEH-22 both target an autoregulatory enhancer believed to maintain ceh-22 expression in pharyngeal muscle (Gaudet and Mango, 2002; Kuchenthal et al., 2001) . However, little is known about how genes such as ceh-22 are initially activated by PHA-4 in the early stages of pharyngeal cell type differentiation.
ceh-22 is expressed exclusively in the pharyngeal muscles, and it is the earliest known marker of pharyngeal muscle differentiation (Okkema and Fire, 1994) . ceh-22 expression begins shortly after the formation of the pharyngeal primordium at the bean stage of development (approximately 380 min post first cleavage), and it is regulated at the transcriptional level (Kuchenthal et al., 2001; Okkema and Fire, 1994) . The ceh-22 promoter is contained in the 1.9 kb intergenic region upstream of ceh-22, and two enhancers in this promoter region contribute differently to ceh-22 expression (Kuchenthal et al., 2001) . The proximal enhancer, located just upstream of the gene, becomes active exclusively in the pharyngeal muscles after the onset of endogenous ceh-22 expression. It contains an autoregulatory site targeted by CEH-22 and is likely to maintain ceh-22 expression. In contrast, the distal enhancer, located approximately 1.4 kb upstream of the gene, becomes active in the pharynx at the bean stage when endogenous ceh-22 expression initiates. Later the distal enhancer becomes more broadly active in other pharyngeal cell types as well as outside the pharynx in body wall muscles. A truncated ceh-22 promoter lacking the distal enhancer becomes active only after the onset of endogenous ceh-22 (Gaudet and Mango, 2002) . We hypothesize that the distal enhancer is a crucial regulatory sequence initiating ceh-22 expression in response to signals specifying pharyngeal muscle fate (Kuchenthal et al., 2001) .
In this paper, we characterize the ceh-22 distal enhancer using a combination of functional and comparative analyses. This enhancer consists of three separable subelements, which we call DE1, DE2, and DE3, with different cell type specificities that contribute additively to distal enhancer activity. DE3 is a potent pharyngeal muscle-specific enhancer, and it is strongly conserved in the related nematode Caenorhabditis briggsae. Within DE3, we have identified two separate oligonucleotides termed de199 and de209 sufficient for pharyngeal enhancer activity. These oligonucleotides display distinct cell type specificities, but together recapitulate the activity of DE3. de209 is necessary for DE3 enhancer activity and can specifically activate gene expression in the pharyngeal muscles. de209 binds PHA-4 in vitro, and ectopic PHA-4 expression can activate this enhancer outside the pharynx in vivo. We hypothesize that ceh-22 expression is initiated by a combinatorial action of PHA-4 and other transcriptional activators, and repressors that recognize sequences within the distal enhancer.
Materials and methods

Plasmids and general methods for nucleic acid manipulations
Standard methods were used to manipulate plasmid DNAs and oligonucleotides (Ausubel, 1990) . The distal enhancerDlacZ fusion (pOK103.12) used to initiate this analysis was described previously (Kuchenthal et al., 2001) . All enhancer constructs were assayed using the Dpes-10DlacZ fusion vector pPD95.27 kindly provided by Dr. Andrew Fire, Carnegie Institution of Washington (Seydoux and . DE1, DE2, and DE3 fragments were generated by PCR using primers with incorporated SphI or XbaI restriction sites allowing ligation upstream of the Dpes-10DlacZ reporter (DE1 primers: PO57 ACATG-CATGCCGGATATAAACACTGA, PO58 GCTCTA-GAGTCGACGTCAATGATAG; DE2 primers: PO55 A C AT G C AT G C TA A G AT TA G G G A A C G A , P O 5 9 GCTCTAGAGTGTTTATATCCGGTT; DE3 primers: PO54 ACATGCATGCGGATCCAAAAATACGGC, PO61 GCTCTAGAATCCATTTTGTGTGTG). Combinations of these fragments were subsequently cloned upstream of Dpes-10DlacZ using standard cloning techniques. Oligonucleotides assayed for enhancer activity contained 5V nonpalindromic overhangs for ligation as head-to-tail concatenates into the StyI site of pPD95.27 as described previously (Kuchenthal et al., 2001; Okkema and Fire, 1994; Thatcher et al., 2001) . Double stranded de199alt (PO415 CCTCTGTGTAGGTGGAGAAACGCACACACAAA/ PO416 GAGGTTTGTGTGTGCGTTTCTCCACCTA-CACA) and de200alt (PO417 CCTCTGGACAAACAGA-TA A C G C G G C C G TAT T T / P O 4 1 8 G A G G A A A -TACGGCCGCGTTATCTGTTTGTCCA) oligonucleotides were ligated using complementary ends, end-filled using T4 DNA polymerase, and cloned into the StuI site of pPD95.27. Oligonucleotide enhancers were sequenced to confirm the number and integrity of the inserts.
de199 and de209 sequences were deleted from DE3 using a modification of a procedure described in Xu and Gong (1999) . Briefly, the entire plasmid pOK125.25 was amplified by inverse PCR using primers that anneal in DE3 just outside of de199 (PO267 CCGCTCGAGTCAG-CAAGGAACAAGAAGT/PO268 CGCCTCGAGCA-CAAAATGGATTCTAGAGGA) or de209 (PO269 GGAGATCTTGGATCCGCATGCAA/PO270 GGA-GATCTTACCGTAATCTTTTTTGCTC). The PCR product was recircularized using either XhoI (DE3(de199)) or BglII (DE3(Dde209)) restriction sites present in the primers. The DE3(DPHA-4) enhancer was constructed by inserting the double-stranded oligonucleotide (PO610 AGCTTG-CATGCGGATCCAAAAATACGGCCGCGTA/PO611 GATCTACGCGGCCGTATTTTTGGATCCGCATGCA) into HindIII and BglII digested pOK151.06. The mutated enhancers were sequenced and recloned into pPD95.27.
Fosmids containing Cb-ceh-22 were identified by hybridizing a filter array of C. briggsae genomic DNA (Genome Systems) with a ceh-22 cDNA probe, and the BAC clone CB021D15 (accession number , AC099762) containing these fosmids was identified and sequenced by the Genome Sequencing Center (Washington University). The Cb-ceh-22 promoter fragment containing the entire intergenic region between Cb-ceh-22 and the upstream gene Cb-twk-9 was amplified using primers PO419 (GCACTG-C A G T C AT T T G C T T C A A C G T G G ) a n d P O 4 2 0 (CCCCCGGGCCGATGCGATAGAAGGC), and inserted into pPD21.28 (Fire et al., 1990) digested with XmaI and PstI. Sequences of all plasmid constructs are available from the authors.
Handling of nematodes and transformation assays C. elegans were grown under standard conditions (Lewis and Fleming, 1995) . Expression of lacZ in F 1 transformants was assayed as previously described (Kuchenthal et al., 2001; Okkema et al., 1993; Thatcher et al., 2001) . Briefly, plasmid DNAs were injected into the germ line of adult hermaphrodites (Mello and Fire, 1995) , and F 1 progeny was stained for h-galactosidase activity as larvae and adults (Fire, 1992) . Most plasmids, with exceptions described in Table 1 , were injected as gel purified HindIII -SpeI fragments to minimize background h-galactosidase expression in marginal cells from enhancers in the plasmid backbone. Enhancer constructs were injected at 50-100 Ag/ml either with or without 25 Ag/ml egl-15DlacZ plasmid NH#307 (kindly provided by C. Branda and M. Stern, Yale University).
Transgenic strains OK296, OK297, OK298 express lacZ under the control of the C. briggsae ceh-22 promoter. These Data represent percentages of cells of individual cell types in (n) F 1 transformants expressing h-galactosidase. Each reporter plasmid was linearized (exceptions are noted below) as described in the text and Materials and methods and injected alone into the germlines of adult hermaphrodites (P 0 ). All pharyngeal cells expressing h-galactosidase were scored in F 1 transformants. a Total number of h-galactosidase positive cells in the pharynxes of (n) F 1 transformants. b These plasmids were not linearized before injection. strains contain simple extrachromosomal arrays and were generated by injecting plasmid pOK164.01 (25 Ag/ml) in combination with pRF4 (100 Ag/ml) (Mello and Fire, 1995) .
Ectopic expression of transcription factors
The effect of ectopic expression of pha-4 and elt-5 on the activity of de209 was examined in F 1 transformants as previously described (Kalb et al., 2002; Kuchenthal et al., 2001) . Strain JM70 contains a chromosomally integrated array bearing pJM92 for expressing pha-4 under the control of the hsp16-2 promoter (Kalb et al., 1998) , and strain JR869 (a gift from M. Maduro and J. Rothman) contains an extrachromosomal array expressing elt-5 under the control of the hsp16-2 promoter. Transgenic JM70 and JR869 adult hermaphrodites were injected with the plasmid pOK138.18 and allowed to produce progeny for 6 -7 days at 16jC. The F 1 broods were subjected to two heat shocks for 2 h each at 33jC with an intervening 30 min recovery period. They were then incubated 17 -19 h at 25jC and stained to detect h-galactosidase expression (Fire, 1992) .
Gel mobility shift assays
PHA-4B protein (a gift from J. Kalb and J. McGhee) was incubated in 20-Al binding reactions containing 25 mM HEPES (pH 7.5), 50 mM KCl, 0.1 mM ZnSO 4 , 1 mM DTT, 0.2 mg/ml BSA, 10% glycerol, 0.1% NP-40, 50 ng/Al poly dI/dC, 50 ng/Al poly dA/dT, 12.5 ng/Al protein, and 2500 cpm/Al de209 probe at room temperature for 20 min and electrophoresed on a 5% non-denaturing acrylamide gel at 4jC. Labeled de209 was prepared by annealing oligonucleotides PO209 (CAAGTGGACAAACAGATAACG-C G G C C G TAT T T ) a n d P O 2 1 0 ( C T T G A A A -TACGGCCGCGTTATCTGTTTGTCCA), and end-filling with the Klenow fragment of DNA Polymerase I in the presence of a[ 32 P]-dCTP (800 Ci/mmol). For competition experiments, unlabeled de209mut1-1 was prepared by annealing oligonucleotides PO275 (CAAGTGCCCGGG-CAGATAACGCGGCCGTATTT) and PO276 (CTTGAAA-TACGGCCGCGTTATCTGCCCGGGCA), while unlabeled de209mut2 was prepared by annealing oligonucleotides PO238 (CAAGTGGACAAAACTCGAACGCGGCCG-TATTT) and PO239 (CTTGAAATACGGCCGCGTTC-GAGTTTTGTCCA).
Results and discussion
The distal enhancer is modular and contains multiple functionally important sequences
The ceh-22 distal enhancer is a potent pharyngeal muscle enhancer ( Fig. 1A ; (Kuchenthal et al., 2001) ). In transgenic C. elegans, it specifically activated frequent expression of a Dpes-10DlacZ reporter gene in the ceh-22 expressing pha-ryngeal muscles (m1, m3, m4, m5, and m7) in an F 1 expression assay ( Fig. 2A , Table 1 ). Expression was also sometimes observed in the pharyngeal marginal cells (Table  1) , but this activity was due at least in part to vector sequences, as assays with a fragment containing only the distal enhancerDDpes-10DlacZ reporter resulted in decreased expression in the marginal cells (data not shown). This pharyngeal expression pattern was similar to that observed in lines stably transformed with this plasmid (Kuchenthal et al., 2001) , although occasional distal enhancer activity was observed in non-muscle cells in these lines (Kuchenthal et al., 2001) .
The distal enhancer is modular, and three fragments that we call the DE1, DE2, and DE3 subelements ( Fig. 1B) retained pharyngeal muscle enhancer activity. DE1 and DE3 predominantly activated transcription in the m3, m4, m5, and m7 pharyngeal muscles, while DE3 also activated occasional expression in the pharyngeal -intestinal valve and body wall muscle cells (Figs. 2B, D, Table 1 , and data not shown). Despite these similar activity patterns, DE1 and Table 2. DE3 share no strong sequence similarity, suggesting these subelements are targeted by different regulatory factors. In contrast, DE2 was highly active in the m1 pharyngeal muscle cells (Fig. 2C, Table 1 ), a specialized syncytial cell forming a thin sheet at the anterior of the pharynx (Albertson and Thomson, 1976) . The m1 cells show no clear lineal relationship (Sulston et al., 1983) , suggesting that DE2 responds to signals that specify m1 cell fate rather than lineal cues. We next assayed combinations of DE1, DE2, and DE3 for enhancer activity, and found they generally activated reporter gene expression in an additive rather than a synergistic pattern (Table 1) . DE3 was unique in that it was a very strong pharyngeal muscle enhancer when assayed in two copies (Table 1, Fig. 2E ), and it was active in all the larger pharyngeal muscles, including m6 in which neither ceh-22 nor the intact distal enhancer was frequently active (Kuchenthal et al., 2001; Okkema and Fire, 1994) . Taken together, these results suggest multiple developmental signals converge on the distal enhancer to regulate ceh-22 expression, and DE3 is an essential target of factors promoting pharyngeal muscle differentiation.
Functionally important sequences are conserved in C. briggsae Functional regulatory sequences are generally conserved between C. elegans and the related nematode C. briggsae (Kent and Zahler, 2000) . To facilitate a comparative analysis of the ceh-22 promoter, we identified clones containing C. briggsae ceh-22 (see Materials and methods) and, in collaboration with the Genome Sequencing Center (GSC, Washington University, St. Louis), sequenced the BAC clone CB021D15 containing Cb-ceh-22 (GenBank accession number , AC099762). This BAC contains approximately 98 kb of sequence, which is highly syntenic with the C. elegans ceh-22 region (data not shown).
We found that the Cb-ceh-22 promoter directed pharyngeal muscle expression in transgenic C. elegans. A Cb-ceh-22DlacZ was first expressed weakly in the pharynx at the bean stage, but expression was considerably increased by the comma stage ( Fig. 3A and data not shown) . Expression continued through the remainder of development and was found in the m1, m3, m4, m5, and m7 pharyngeal muscle cells, mc1 marginal cells, and occasionally in pharyngeal neurons (Fig. 3B) . Thus, the temporal and cell type specificity of Cb-ceh-22 promoter in C. elegans was similar to Ce-ceh-22, although the frequency of lacZ expression was lower and many transgenics exhibited mosaic expression patterns. Thus, sequences regulating ceh-22 expression are conserved between C. elegans and C. briggsae, although one or more sequences required for optimal expression may have diverged between the two species.
Alignment of the Ce-ceh-22 and Cb-ceh-22 promoters revealed several regions of high sequence conservation, and these predominantly localize to functionally identified enhancers (Fig. 3C ). Within the distal enhancer, the most extended region of sequence identity included DE3 and continued approximately 130 bp downstream of the distal enhancer ( Fig. 3D ), suggesting that DE3 is part of a larger regulatory element. Within the proximal enhancer, sequences just upstream of the ceh-22 coding sequence and sequences including an autoregulatory site are nearly identical in C. briggsae (Kuchenthal et al., 2001) . Several predicted binding sites for PHA-4 (Gaudet and Mango, 2002) are conserved in both the proximal and distal enhancers, while consensus CEH-22 sites are clustered near the autoregulatory site in the proximal enhancer ( Fig. 3C) (Kuchenthal et al., 2001) . The location of conserved PHA-4 and CEH-22 sites in the proximal enhancer is reminiscent of sites within the myo-2 Fig. 2 . Three distinct subelements contribute to distal enhancer activity. DIC micrographs showing h-galactosidase expression in adult F 1 transformants bearing ceh-22 distal enhancer fragments controlling expression of a Dpes-10DlacZ reporter as described in the text. h-galactosidase activity is localized in cell nuclei, and representative nuclei expressing h-galactosidase are indicated (m indicates pharyngeal muscle; mc indicates pharyngeal marginal cell). While DE1, DE2, DE3, and 2XDE3 are each effective pharyngeal muscle enhancers when assayed in F 1 transformants, they are weakly active in stably transformed lines (data not shown). Similar observations have been made using partial enhancers from myo-2 (Okkema, and Fire, 1994; P. Okkema, unpublished) . enhancer (Okkema and Fire, 1994) , suggesting that the combined action of these factors may be a common mechanism for regulating pharyngeal muscle-specific genes.
Two distinct sequences within DE3 are sufficient to enhance pharyngeal gene expression DE3 retains strong pharyngeal muscle enhancer activity very similar to the complete distal enhancer and is highly conserved in C. briggsae, suggesting it is an important site for ceh-22 regulation. To identify short sequence elements contributing to its activity, we assayed eight overlapping oligonucleotides spanning DE3 for pharyngeal muscle enhancer activity (Fig. 1C) . These oligonucleotides were cloned in five copies upstream of Dpes-10DlacZ and assayed for pharyngeal enhancer activity in F 1 transformants. Initially, these constructs were assayed together with an egl-15DlacZ reporter, which is expressed in the hypodermis but not in the pharynx (Table 2) . This procedure allowed us to recognize all transformants expressing hgalactosidase and to determine the percentage of these transformants expressing Dpes-10DlacZ in the pharynx (Kuchenthal et al., 2001) . Without any oligonucleotide, the Dpes-10DlacZ reporter in pPD95.27 was expressed in a small number of pharyngeal cells (generally one muscle or marginal cell) in 20% of transformants, and constructs containing most of the oligonucleotide multimers were expressed at similar or lower frequency than the parental vector (Table 2 ). In contrast, constructs containing either the 5Xde199 or 5Xde209 enhancers were expressed significantly more frequently and in more cells in the pharynx than Dpes-10DlacZ (Table 2) . Enhancer activity of these oligonucleotides depended on ceh-22 sequences, as enhancers containing six copies of these oligonucleotides ligated using a different linker sequence, 6Xde199alt and 6Xde209alt (see Materials and methods), activated pharyngeal h-galactosidase expression at a frequency nearly identical to the original 5Xde199 and 5Xde209 enhancers ( Table 2) . Within DE3, the de199 and de209 oligonucleotides are partially conserved in C. briggsae, and the spacing between these sequences is identical ( Fig. 3D ), suggesting that factors binding them may interact in a spatially constrained manner.
We next examined cell type specificity of the de199 and de209 multimer enhancers by assaying their activity without is numbered according to F29F11 (GenBank accession number Z73974). C. briggsae ceh-22 is numbered according to CB021D15 (accession number AC099762). The positions of the enhancers described in the text are shown below. de199 and de209 oligonucleotide enhancers are indicated by white squares within DE3. pe39 oligonucleotide enhancer (Kuchenthal et al., 2001 ) is shown as a white square within the proximal enhancer. Most of the conserved sequences are located within the proximal and distal enhancers as well as downstream of the distal enhancer. The positions of conserved CEH-22 and PHA-4 consensus binding sites are shown as gray and black arrowheads, respectively. A conserved PHA-4 site is located within de209 and two conserved CEH-22 sites are located within pe39 (Kuchenthal et al., 2001) . (D) A ClustalW alignment of the DE3 fragment and conserved downstream sequences with the corresponding sequence in the Cb-ceh-22 promoter. DE3 (shaded box) is highly conserved between the two species. Positions of the de199 and de209 oligonucleotides and the deletion in DE3(DPHA-4) are indicated.
the egl-15DlacZ co-injection marker and found that each can activate transcription in the pharyngeal muscles, although they exhibit distinct patterns of activity in other cell types. 5Xde199 and 6Xde199alt activated reporter gene expression more broadly than DE3 in most pharyngeal muscles and in marginal cells, with occasional expression in pharyngeal epithelial cells and in body wall muscles (Table 1, Fig. 4A, and data not shown) . In comparison, 5Xde209 and 6Xde209alt activated reporter expression in a pattern similar to DE3 in the pharyngeal muscles, with occasional expression in the m6 muscles, marginal cells, and pharyngeal -intestinal valve cells (Table 1, Fig. 4B, and data not shown). The parental Dpes-10DlacZ reporter in pPD95.27 was occasionally expressed in posterior gut cells, with < 0.25 h-galactosidase expressing pharyngeal cellstransformant (data not shown).
To determine how de199 or de209 contribute to DE3 activity, we deleted these sequences and assayed enhancer activity wild-type DE3 activated pharyngeal expression in 38% of the transformants (Table 2), and as described above, this expression was predominantly in ceh-22 expressing pharyngeal muscles and occasional pharyngeal intestinal valve and body wall muscle cells (Table 1 and data not shown). Deletion of de199 resulted in only a moderate decrease in enhancer activity (Table 2-DE3(Dde199)), and no change in cell type specificity (Table 1 and data not shown). In contrast, deletion of de209 resulted in a substantial decrease in enhancer activity (Table 2 -DE3(Dde209)), and this activity was specifically reduced in the pharyngeal muscles and the pharyngeal -intestinal valve cells (Table 1 and data not shown). To ask if de199 and de209 function together to activate gene expression, we compared enhancer activity of a single copy of either de199 or de209 with an enhancer containing one copy of both de199 and de209. In assays with the egl-15DlacZ coinjection marker, the 1Xde199 and 1Xde209 enhancers exhibited little or no pharyngeal enhancer activity (Table  2 ). In contrast, 1Xde199 + 1Xde209 exhibited more frequent pharyngeal enhancer activity approaching that of the full DE3 fragment (Table 2 ). In assays without egl-15DlacZ, 1Xde199 + 1Xde209 activated frequent reporter gene expression in the pharyngeal muscle cells and occasionally in pharyngeal epithelial cells and marginal cells ( Table 1, Fig.  4C , and data not shown). These data indicate that de209 is required for DE3 pharyngeal enhancer activity, and the combination of de209 and de199 activates transcription similarly to intact DE3.
de199 contains distinct activating and repressing sites
We assayed enhancer activity of de199 derivatives containing short substitutions (Fig. 5A) , and found evidence for multiple activating and repressing sites. 5Xde199mut5 exhibited dramatically reduced pharyngeal enhancer activity when assayed with egl-15DlacZ (Table  2) , indicating that this mutation affects an activator binding site. In contrast, 5Xde199mut2 and 5Xde199mut4 exhibited increased pharyngeal enhancer activity ( Table  2) , indicating that these mutations affect repressor binding sites. Compared to wild-type 5Xde199, 5Xde199mut2 and 5Xde199mut4 exhibited different effects on enhancer cell type specificity. When assayed alone, 5Xde199mut2 activated lacZ expression in a similar pattern of cells as wildtype 5Xde199, although expression was more frequent in the m3 and m4 pharyngeal muscles and less frequent in body wall muscles (Table 1 and data not shown). 5Xde199mut4 activated transcription more frequently than wild-type 5Xde199 in most pharyngeal cell types including the muscles and epithelial cells, as well as pharyngeal neurons and the pharyngeal -intestinal valve cells, where 5Xde199 activity was not observed (Table 1, Fig. 4D , and data not shown). Therefore, two repressors with different functions may bind de199.
PHA-4 targets de209 in vitro and in vivo
The pan-pharyngeal factor PHA-4 is believed to regulate all genes expressed in the pharynx (Gaudet and Mango, Each enhancer construct was assayed as a fusion to Dpes-10DlacZ.
Reporter plasmids were co-injected into the germline of adult hermaphrodites (P 0 ) with the egl-15::lacZ fusion plasmid NH#307. The number of F 1 transformants expressing h-galactosidase in the pharynx was divided by the total number of transformants (n). a Location of the oligonucleotide using the numbering scheme in the F29F11 sequence (accession number Z73974).
2002)
, but in most cases, it is not known how PHA-4 differentially regulates genes expressed in specific pharyngeal cell types. This situation is best understood in the later stages of pharyngeal muscle differentiation, where the pharyngeal muscle-specific myosin gene myo-2 is activated by the combined activities of PHA-4 and CEH-22 (Kalb et al., 1998; Okkema and Fire, 1994) . Likewise, maintained expression of ceh-22 may involve both PHA-4 and CEH-22 (Gaudet and Mango, 2002; Kuchenthal et al., 2001) . However, we do not know if PHA-4 directly initiates ceh-22 expression, and if so, how ceh-22 is specifically activated in the pharyngeal muscles. DE3 contains two conserved sites similar to the predicted PHA-4 consensus TRTTKRY within de209 (Gaudet and Mango, 2002) (Fig. 5B) . We asked if PHA-4 recognized these sites in vitro, and found it bound de209 (Fig. 5C) . A mutation in de209mut1-1 disrupting PHA-4 site 1 did not eliminate binding, while a mutation in de209mut2 disrupting both sites completely eliminated binding (Figs. 5B, C) . These results indicate that PHA-4 binding is specific, although we cannot distinguish whether it binds both sites or only site 2. PHA-4 binding appears essential for activity of the DE3 enhancer, as deletion of these sites resulted in a The wild-type oligonucleotide sequence is shown in both strands, while the mutant sequences are shown only in the top strand with the altered bases indicated in lower case. de209 contains two possible binding sites for PHA-4 (boxed). Site 1 is a perfect match to the predicted TRTTKRY consensus (Gaudet and Mango, 2002) on the bottom strand, while site 2 is an incomplete match, with a C instead of a T at position 4. Site 1 is altered from this consensus in de209mut1-1, while both sites are disrupted in de209mut2. (C) An electrophoretic mobility shift assay indicating PHA-4 binds specifically to de209 in vitro. PHA-4 was incubated with 32 P-labeled de209 either in the absence (lane 2) or the presence (lanes 3 -11) of the indicated competitors. Unlabeled competitors were present in a 10-fold (lanes 3, 6, 9), 50-fold (lanes 4, 7, 10) , or 250-fold (lanes 5, 8, 11) excess. substantial loss of enhancer activity (Fig. 3D , Table 2 -DE3(DPHA-4)).
Ectopic pha-4 expression could also activate the de209 enhancer in vivo. Expression of pha-4 using a heat shock promoter resulted in a large increase in the percent transformants expressing 5Xde209DDpes-10DlacZ outside the pharynx when compared to wild-type worms (Table 3 ). While de209 also contains a consensus GATA family factor binding site (Ko and Engel, 1993; Merika and Orkin, 1993) , we found that ectopic expression of the ELT-5 GATA factor resulted in only a weak increase in ectopic 5Xde209DDpes-10DlacZ expression. Interestingly, ectopic pha-4 only activated the 5Xde209 enhancer only in body wall muscles, despite the fact the heat shock promoter is active in many C. elegans tissues (Stringham et al., 1992) . A similar restriction to body wall muscle was observed when ectopic ceh-22 was used to activate a responsive reporter (Kuchenthal et al., 2001) , suggesting that factors functioning in combination with PHA-4 and CEH-22 are also present in body wall muscle cells.
Together these results suggest that PHA-4 activates ceh-22 expression directly through de209, and that other factors binding de209 function with PHA-4 to specifically activate ceh-22 in the pharyngeal muscles. What factors might function with PHA-4 to activate ceh-22 expression? The GATA factor site in de209 overlaps the non-consensus PHA-4 site, and Forkhead and GATA factors have been suggested to function together in other systems to provide a permissive context for gene activation (Zaret, 1999) . C. elegans contains 11 GATA factor genes, and while the de209 enhancer is not activated by ectopic ELT-5, it could be targeted by other GATA factors. The MED-1 and MED-2 GATA factors are expressed early and are required for pharynx produced by the EMS blastomere (Maduro et al., 2001) , and they could directly regulate ceh-22 in EMS-derived pharyngeal muscles. However, de209 is also active in ABa-derived pharyngeal muscles, suggesting that other factors must also target de209.
Likewise, factors bound to de199 and other sites in the distal enhancer could function with PHA-4 to activate ceh-22 expression.
A common feature of C. elegans ceh-22, Drosophila tinman, and vertebrate Nkx2-5 is that they are each expressed early in the myogenic program of muscles that do not express MyoD family factors (Cripps and Olson, 2002; Harvey, 1996) . Are these genes expressed in response to common signals specifying the fate of these muscle types? Our current understanding suggests that the answer is no. BMP-like signals are important for development of both the Drosophila and vertebrate heart, and these signals directly regulate Drosophila tinman and murine Nkx2-5 (Lien et al., 2002; Sparrow et al., 2000; Xu et al., 1998) . In contrast, mutations affecting known BMP-like signaling in C. elegans result in no pharyngeal defects during embryogenesis (for review, see Patterson and Padgett, 2000) , and we have observed no effect of loss of these signaling pathways on activity of the ceh-22 promoter (L. Beaster-Jones and P. Okkema, unpublished) . No consensus Smad binding sites (Johnson et al., 1999; Thatcher et al., 1999; Zawel et al., 1998) conserved between C. elegans and C. briggsae are found in DE3 or the downstream conserved region. GATA factors sites are also essential for activity of the conserved AR2 enhancer in the mouse and Xenopus Nkx2-5 genes (Searcy et al., 1998; Sparrow et al., 2000) . As discussed above, while a GATA site is present in the ceh-22 distal enhancer, none of the C. elegans GATA factors appear to be present in all ceh-22 expressing cells. Finally, wingless/ Wnt signaling has also be shown to regulate tinman and murine Nkx2-5 (Marvin et al., 2001; Pandur et al., 2002; Park et al., 1996; Schneider and Mercola, 2001) . However, pharyngeal defects have not been described for C. elegans Wnt pathway mutants (for review, see Korswagen, 2002) .
Instead, we show here that the Forkhead factor PHA-4 is likely involved in initiating ceh-22 expression. PHA-4 is one of approximately 20 predicted Forkhead domain proteins (Pfam motif PF00250) in C. elegans and is most closely related to Drosophila Forkhead and the vertebrate HNF-3 proteins (Horner et al., 1998; Kalb et al., 1998) . There is no evidence that these or other Forkhead domain proteins are required for tinman or Nkx2-5 expression. Although these factors are co-expressed in pharyngeal endoderm in mouse, an HNF-3 consensus binding site in the phylogenetically conserved murine nkx2-5 AR2 enhancer is not required for enhancer activity either in pharynx or heart (Lien et al., 2002) . (100) Each reporter plasmid was injected into the germline of adult hermaphrodites (P 0 ) of the indicated strains. F 1 transformants recognized because of pharyngeal h-galactosidase expression were scored for expression outside the pharynx. a A chromosomally integrated line expressing pha-4 under the control of the hsp16-2 promoter (Kalb et al., 1998; Stringham et al., 1992) . b An extrachromosomal line expressing elt-5 under the control of the hsp16-2 promoter (Stringham et al., 1992) . Data was normalized for the percentage of progeny segregating the extrachromosomal array.
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